Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Prophylactic Phenobarbital After Neonatal Seizures

ClinicalTrials.gov ID: NCT01089504

Public ClinicalTrials.gov record NCT01089504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prophylactic Phenobarbital After Resolution of Neonatal Seizures

Study identification

NCT ID
NCT01089504
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
University of Rochester
Other
Enrollment
13 participants

Conditions and interventions

Interventions

  • phenobarbital Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
2 Days to 2 Weeks
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
Feb 2, 2016

2010 – 2014

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
University of Arkansas Little Rock Arkansas 72202
University of California San Francisco San Francisco California 94143
Univeristy of Iowa Iowa City Iowa 52242
Johns Hopkins University Baltimore Maryland 21224
Tufts Medical Center Boston Massachusetts 02111
University of Michigan Ann Arbor Michigan 48109
Women & Children's Hospital of Buffalo Buffalo New York 14222
University of Rochester Rochester New York 14642
Forsyth Medical Center Winston-Salem North Carolina 27157
Wake Forest University Winston-Salem North Carolina 27157
Akron Children's Hospital Akron Ohio 44308
Nationwide Children's Hospital Columbus Ohio 43205
Magee Womens Hospital Pittsburgh Pennsylvania 15224
University of Pittsburgh Pittsburgh Pennsylvania 15224
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905
Primary Children's Medical Center Salt Lake City Utah 84108
University of Utah Salt Lake City Utah 84108
University of Virginia Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01089504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2016 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01089504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →